Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Muscleblind-like protein | 0.0142 | 0.167 | 0.3978 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0.0012 | 0.5 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.0254 | 1 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0035 | 0.0254 | 0.5 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.0254 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0088 | 0.0186 |
Schistosoma mansoni | inositol monophosphatase | 0.0035 | 0.0254 | 0.0115 |
Loa Loa (eye worm) | inositol-1 | 0.0035 | 0.0254 | 0.0597 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0225 | 0.2767 | 0.2656 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0088 | 0.3118 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0.0012 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0035 | 0.0254 | 0.5 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0035 | 0.0254 | 0.0115 |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.167 | 0.409 |
Loa Loa (eye worm) | hypothetical protein | 0.0225 | 0.2767 | 0.6796 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0088 | 0.3118 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0088 | 0.0186 |
Echinococcus granulosus | geminin | 0.017 | 0.2042 | 0.2112 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0.0012 | 0.5 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0088 | 0.3118 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0035 | 0.0254 | 1 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0703 | 0.9106 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0088 | 0.3118 |
Echinococcus multilocularis | muscleblind protein | 0.0142 | 0.167 | 0.1543 |
Brugia malayi | Inositol-1 | 0.0035 | 0.0254 | 0.0419 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.0396 | 0.0274 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0151 | 0.0159 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0035 | 0.0254 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0046 | 0.0396 | 0.0274 |
Brugia malayi | tumor suppressor. | 0.0323 | 0.4065 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.167 | 0.409 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0035 | 0.0254 | 0.0105 |
Onchocerca volvulus | 0.0046 | 0.0396 | 0.9524 | |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.0254 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0088 | 0.3118 |
Brugia malayi | hypothetical protein | 0.0225 | 0.2767 | 0.6735 |
Schistosoma mansoni | inositol monophosphatase | 0.0035 | 0.0254 | 0.0115 |
Onchocerca volvulus | 0.0047 | 0.0412 | 1 | |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0031 | 0.0205 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0012 | 0.0593 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0046 | 0.0396 | 0.0776 |
Schistosoma mansoni | hypothetical protein | 0.017 | 0.2042 | 0.2112 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0088 | 0.3118 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0088 | 0.3118 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0088 | 0.0186 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0142 | 0.167 | 0.1543 |
Echinococcus granulosus | muscleblind protein | 0.0142 | 0.167 | 0.1696 |
Echinococcus multilocularis | geminin | 0.017 | 0.2042 | 0.1921 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0088 | 0.3118 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0088 | 0.4266 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0035 | 0.0254 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0412 | 0.0986 |
Echinococcus granulosus | tumor protein p63 | 0.0321 | 0.4044 | 0.4347 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0035 | 0.0254 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0703 | 0.9106 | 0.9093 |
Echinococcus multilocularis | tumor protein p63 | 0.0321 | 0.4044 | 0.3953 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0047 | 0.0412 | 0.0291 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0151 | 0.0343 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0031 | 0.0205 | 1 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0035 | 0.0254 | 0.5 |
Loa Loa (eye worm) | tumor suppressor | 0.0323 | 0.4065 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0703 | 0.9106 | 1 |
Brugia malayi | Temporarily assigned gene name protein 44 | 0.0027 | 0.0151 | 0.0159 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0035 | 0.0254 | 0.5 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0088 | 0.4266 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0225 | 0.2767 | 0.2921 |
Schistosoma mansoni | hypothetical protein | 0.017 | 0.2042 | 0.2112 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 3.46 uM | Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye | Saint Jude. | 20485428 |
EC50 (functional) | = 4.1 uM | Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye | Saint Jude. | 20485428 |
Percent growth inhibition (functional) | = 88.4 % | Plasmodium falciparum 3D7 % growth inhibition at 7uM as measured by YOYO-3 red dye | Saint Jude. | 20485428 |
Percent growth inhibition (functional) | = 105.9 % | Plasmodium falciparum 3D7 % growth inhibition at 7uM as measured by SYBR green dye | Saint Jude. | 20485428 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.